These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 38409844)
1. Clinical Characteristics of COVID-19 in Gynecological Cancer Patients during Chemotherapy-An Observational Study. Li Y; Sang C; Ru X; Wang S; Wang H Discov Med; 2024 Feb; 36(181):393-401. PubMed ID: 38409844 [TBL] [Abstract][Full Text] [Related]
2. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165 [TBL] [Abstract][Full Text] [Related]
3. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease. Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study]. Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study. Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709 [TBL] [Abstract][Full Text] [Related]
7. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy. Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995 [TBL] [Abstract][Full Text] [Related]
8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
10. Universal screening for SARS-CoV-2 infection: a rapid review. Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003 [TBL] [Abstract][Full Text] [Related]
11. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study. Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206 [TBL] [Abstract][Full Text] [Related]
12. Routine blood tests as a potential diagnostic tool for COVID-19. Ferrari D; Motta A; Strollo M; Banfi G; Locatelli M Clin Chem Lab Med; 2020 Jun; 58(7):1095-1099. PubMed ID: 32301746 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China. Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and imaging analysis of neurological complications in critically ill children infected with SARS-CoV-2 Omicron]. Wang X; Qi X; Zhao Y; Wei F; Yang W; Zeng H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1157-1163. PubMed ID: 37987125 [TBL] [Abstract][Full Text] [Related]
15. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337 [TBL] [Abstract][Full Text] [Related]
16. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T; Trials; 2021 May; 22(1):343. PubMed ID: 34001215 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and hematological parameters associated with disease severity in COVID-19 positive pregnant women undergoing cesarean section: A single-center experience. Arslan B; Bicer IG; Sahin T; Vay M; Dilek O; Destegul E J Obstet Gynaecol Res; 2022 Feb; 48(2):402-410. PubMed ID: 34837446 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome. Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750 [TBL] [Abstract][Full Text] [Related]
20. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients. Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]